Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dymista in children with seasonal allergic rhinitis
NCT01915823Phase 3Completed
- Sponsor
- Meda
- Start
- Jul 2013
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of azelastine + fluticasone in seasonal allergic rhinitis (SAR), sponsored by Meda. Started Jul 2013; status: completed.
02
Drugs
azelastine + fluticasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01915823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01915823.